DSIP (Delta Sleep-Inducing Peptide) vs GHRP-2

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

DSIP (Delta Sleep-Inducing Peptide)GHRP-2
CategoryPeptidesPeptides
Standard DoseResearch indicates 100-300 mcg administered before bedtime via subcutaneous injection or intranasal.Research indicates 100-300 mcg administered 1-3 times daily via subcutaneous injection.
Timing30-60 minutes before desired sleep onset. Evening only.On empty stomach, bedtime administration preferred. Wait 2+ hours after last meal.
Cycle Duration2-4 week cycles with equal rest periods to prevent tolerance.8-16 week cycles.
Evidence Levelanimal_plus_anecdotalmoderate_human

Mechanism

DSIP is a naturally occurring nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) originally isolated from rabbit brain hypothalamus in 1977. It modulates GABAergic neurotransmission by potentiating GABA-activated currents in hippocampal and cerebellar neurons while blocking NMDA-activated potentiation in cortical neurons. It also interacts with opioid-associated receptors, modulates serotonin and dopamine systems (increasing serotonin levels), and promotes delta wave (slow-wave) sleep through mechanisms that remain incompletely characterized.

Standard Dosing

Research indicates 100-300 mcg administered before bedtime via subcutaneous injection or intranasal.

Timing

30-60 minutes before desired sleep onset. Evening only.

Cycle Duration

2-4 week cycles with equal rest periods to prevent tolerance.

Side Effects

  • Morning grogginess
  • Vivid dreams
  • Mild headache
  • Transient hypotension

Contraindications

  • Sleep apnea (may worsen)
  • Respiratory depression risk
  • Pregnancy and breastfeeding

Best Stacking Partners

EpitalonSelank
B

GHRP-2

Peptides

Mechanism

GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide GHS-R1a agonist that is the most potent of the GHRP family for GH release. It stimulates pituitary GH secretion through the ghrelin receptor while also modulating hypothalamic GHRH and somatostatin pathways. GHRP-2 increases GH, cortisol, prolactin, and ACTH release, but with less appetite stimulation than GHRP-6. It also has demonstrated anxiolytic properties and sleep-promoting effects.

Standard Dosing

Research indicates 100-300 mcg administered 1-3 times daily via subcutaneous injection.

Timing

On empty stomach, bedtime administration preferred. Wait 2+ hours after last meal.

Cycle Duration

8-16 week cycles.

Side Effects

  • Water retention
  • Moderate hunger increase (less than GHRP-6)
  • Cortisol elevation
  • Prolactin elevation
  • Tingling
  • Vivid dreams

Contraindications

  • Active cancer
  • Cushing's syndrome
  • Hyperprolactinemia
  • Pregnancy and breastfeeding

Best Stacking Partners

CJC-1295 (no DAC)SermorelinBPC-157

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →